IL6 and hepatocellular carcinoma: In mouse models, ghrelin inhibits HCC progression by reducing TG content and cytokines such as TNF-α as well as IL-6, and alleviates lipotoxicity by stimulating autophagy and inhibiting nuclear factor-κB (NF-ĸB) pathway (40).